The FDA will be reviewing a new experi... - Lung Cancer Support

Lung Cancer Support

3,990 members2,163 posts

The FDA will be reviewing a new experimental treatment for lung cancer

MFH_Advocate profile image
0 Replies

Some of you may have seen the recent news about an experimental drug called brigatinib. This drug is not currently FDA approved, but studies are ongoing and initial results are encouraging. This drug is being studied in patients who have ALK-positive non-small cell lung cancer.

This news highlights the efforts of researchers, patients who enrolled in clinical trials, and the commitment of the FDA to review much needed treatment options for lung cancer.

As Dr. Corey Langer states in the article, treatments may stop working in many patients and it is hoped that brigatinib might “provide patients and their oncologists with a new treatment option.”

More information can be found here: onclive.com/web-exclusives/...

Written by
MFH_Advocate profile image
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...

You may also like...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

fda.gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-first-line-treatment-me

Lung cancer stage 4 and treatment

also have stage 4 non small cell lung cancer. I just had my 2nd treatment of chemotherapy and...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

the full FDA press release:...

Lung Cancer Treatment

Have been diagnosed with lung cancer again (but now on the right), 6 years later, but this time they

Cuban vaccination to cure lung cancer

this vaccination Patients should be aware and may be pay farewell to chemical drugs